Home Amines 1020251-53-9
1020251-53-9,MFCD09955575
Catalog No.:AA0006A4
1020251-53-9 | Benzamide, N-[(3,4-dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitro-
Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
4 weeks  
$322.00   $225.00
- +
2mg
4 weeks  
$393.00   $275.00
- +
5mg
4 weeks  
$679.00   $475.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0006A4
Chemical Name:
Benzamide, N-[(3,4-dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitro-
CAS Number:
1020251-53-9
Molecular Formula:
C19H23N3O6
Molecular Weight:
389.4024
MDL Number:
MFCD09955575
IUPAC Name:
N-[(3,4-dimethoxyphenyl)methyl]-2-(1-hydroxypropan-2-ylamino)-5-nitrobenzamide
InChI:
InChI=1S/C19H23N3O6/c1-12(11-23)21-16-6-5-14(22(25)26)9-15(16)19(24)20-10-13-4-7-17(27-2)18(8-13)28-3/h4-9,12,21,23H,10-11H2,1-3H3,(H,20,24)
InChI Key:
ZISFCTXLAXIEMV-UHFFFAOYSA-N
SMILES:
OCC(Nc1ccc(cc1C(=O)NCc1ccc(c(c1)OC)OC)[N+](=O)[O-])C
Properties
Computed Properties
 
Complexity:
514  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
389.159g/mol
Formal Charge:
0
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
389.408g/mol
Monoisotopic Mass:
389.159g/mol
Rotatable Bond Count:
8  
Topological Polar Surface Area:
126A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.7  

Synonyms
 
benzamidenafil 
Xanthoanthrafil 
BCP28660 
AKOS028114492 
ACM1216710836 
RT-017556 
FT-0675867 
Y0506 
J-000540 
Benzamide, N-[(3,4-dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitro- 
N-[(3,4-Dimethoxyphenyl)methyl]-2-[(2-hydroxy-1-methylethyl)amino]-5-nitro-benzamide 
(R)-Xanthoanthrafil 
rac Xanthoanthrafil 
(S)-Xanthoanthrafil 
rac Xanthoanthrafil-d3 
UNII-B6ZMZ878RF 
B6ZMZ878RF 
C19H23N3O6 
FR 226807 
CID10110873 
N-[(3,4-dimethoxyphenyl)methyl]-2-(1-hydroxypropan-2-ylamino)-5-nitro-benzamide 
1216710-83-6 
247567-47-1 
1020251-53-9 
247568-68-9 
Benzamidenafil 
rac-Xanthoanthrafil 
Xanthoanthrafil-d6 
SCHEMBL688476 
CTK8F1140 
N-[(3,4-dimethoxyphenyl)methyl]-2-[[(2S)-1-hydroxypropan-2-yl]amino]-5-nitrobenzamide 
Literature

Title: Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement.

Journal: Journal of pharmaceutical and biomedical analysis 20080609

Title: Determination of (R)-xanthoanthrafil, a phosphodiesterase-5 inhibitor, in a dietary supplement promoted for sexual enhancement.

Journal: Chemical & pharmaceutical bulletin 20080201

Title: Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats.

Journal: European journal of pharmacology 20030912

Title: FR226807: a potent and selective phosphodiesterase type 5 inhibitor.

Journal: European journal of pharmacology 20011005

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Q & A